Molecular profiling of gene-edited cells reveals shared drug-resistance mechanisms

Researchers developed PerturbFate, a platform to track gene expression and chromatin changes in gene-edited cells. When applied to skin-cancer cells, it revealed that diverse genetic perturbations linked to tumor resistance lead to a common dedifferentiated state.